Search research articles
Contact Us
Filters
Showing results (11-20 of 19) with videos related to
Page
of 2
Sort By:
You have reached the last page of results.
This site can display upto 19 results.
The Journal of the Acoustical Society of America
|
April 1, 1995
Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. II. Asymmetry in L1,L2 space
M L Whitehead, B B Stagner, M J McCoy, et al.
Pathology
|
November 6, 2017
The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3
T J Miller, M J McCoy, C Hemmings, et al.
Pathology
|
December 4, 2016
Objective analysis of cancer stem cell marker expression using immunohistochemistry
T J Miller, M J McCoy, C Hemmings, et al.
British Journal of Cancer
|
August 23, 2012
Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies
M J McCoy, R A Lake, R G van der Most, et al.
Annals of the Rheumatic Diseases
|
October 15, 2009
Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial
S M M Verstappen, M J McCoy, C Roberts, et al.
Ear and Hearing
|
December 1, 1995
Time-windowing of click-evoked otoacoustic emissions to increase signal-to-noise ratio
M L Whitehead, A M Jimenez, B B Stagner, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 25, 2009
The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
M J Harrison, L M Davies, N J Bansback, et al.
British Journal of Cancer
|
December 10, 2015
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
M J McCoy, C Hemmings, T J Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
A K Nowak, A M Cook, A M McDonnell, et al.
Page
of 2
Search research articles
Search
Showing results (11-20 of 19) with videos related to
Sort By:
Page
of 2
You have reached the last page of results.
This site can display upto 19 results.
The Journal of the Acoustical Society of America
|
April 1, 1995
Dependence of distortion-product otoacoustic emissions on primary levels in normal and impaired ears. II. Asymmetry in L1,L2 space
M L Whitehead, B B Stagner, M J McCoy, et al.
Pathology
|
November 6, 2017
The prognostic value of cancer stem-like cell markers SOX2 and CD133 in stage III colon cancer is modified by expression of the immune-related markers FoxP3, PD-L1 and CD3
T J Miller, M J McCoy, C Hemmings, et al.
Pathology
|
December 4, 2016
Objective analysis of cancer stem cell marker expression using immunohistochemistry
T J Miller, M J McCoy, C Hemmings, et al.
British Journal of Cancer
|
August 23, 2012
Post-chemotherapy T-cell recovery is a marker of improved survival in patients with advanced thoracic malignancies
M J McCoy, R A Lake, R G van der Most, et al.
Annals of the Rheumatic Diseases
|
October 15, 2009
Beneficial effects of a 3-week course of intramuscular glucocorticoid injections in patients with very early inflammatory polyarthritis: results of the STIVEA trial
S M M Verstappen, M J McCoy, C Roberts, et al.
Ear and Hearing
|
December 1, 1995
Time-windowing of click-evoked otoacoustic emissions to increase signal-to-noise ratio
M L Whitehead, A M Jimenez, B B Stagner, et al.
Quality of Life Research : an International Journal of Quality of Life Aspects of Treatment, Care and Rehabilitation
|
September 25, 2009
The comparative responsiveness of the EQ-5D and SF-6D to change in patients with inflammatory arthritis
M J Harrison, L M Davies, N J Bansback, et al.
British Journal of Cancer
|
December 10, 2015
Low stromal Foxp3+ regulatory T-cell density is associated with complete response to neoadjuvant chemoradiotherapy in rectal cancer
M J McCoy, C Hemmings, T J Miller, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
September 20, 2015
A phase 1b clinical trial of the CD40-activating antibody CP-870,893 in combination with cisplatin and pemetrexed in malignant pleural mesothelioma
A K Nowak, A M Cook, A M McDonnell, et al.
Page
of 2